Takeda Oncology Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Takeda Oncology's estimated annual revenue is currently $434.6M per year.(i)
  • Takeda Oncology's estimated revenue per employee is $201,000

Employee Data

  • Takeda Oncology has 2162 Employees.(i)
  • Takeda Oncology grew their employee count by 1% last year.

Takeda Oncology's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Chief Staff, GMAOReveal Email/Phone
3
Head Evidence Generation, Global Medical AffairsReveal Email/Phone
4
Head U.S. Strategy & OperationsReveal Email/Phone
5
Head Patient Advocacy & EngagementReveal Email/Phone
6
Head US Insights & AnalyticsReveal Email/Phone
7
Head US Oncology Pricing, Contracting & Health EconomicsReveal Email/Phone
8
Associate Director, Global Program Management, Pediatric ProgramsReveal Email/Phone
9
Chief Counsel & Chief Compliance OfficerReveal Email/Phone
10
Sr. Director ODDU, Head Cold-to-Hot BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1459.1M38606%N/AN/A
Add Company

What Is Takeda Oncology?

Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company.

keywords:N/A

N/A

Total Funding

2162

Number of Employees

$434.6M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Takeda Oncology News

2022-04-13 - AACR: By microdosing tumors, Takeda and Presage examine ...

In early studies of two therapies presented at the annual meeting of the American Association for Cancer Research, researchers at Presage and Takeda showed that...

2022-04-06 - Amid Exkivity launch, Takeda beefs up in-house digital ...

With the launch of its new niche lung cancer drug Exkivity in September last year and a slew of precision cancer meds in the pipeline, Takeda Oncology is...

2022-03-22 - China approves Takeda cancer drug - Chinadaily.com.cn

Japanese pharmaceutical company Takeda announced on Friday that Brigatinib, an innovative lung cancer drug, has been approved by China's...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$821.8M21749%N/A
#2
$964.6M2237N/AN/A
#3
$555.5M2240-4%$96.5M
#4
$477.5M243634%N/A
#5
$481.1M2658N/AN/A